SELX:NASDAQSemilux International Ltd. Analysis
Data as of 2026-06-11 - not real-time
$0.34
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Semilux International Ltd. (SELX) trades at roughly $0.34, dramatically below the DCF‑derived fair value of about $6.63, indicating a deep discount. However, the company is confronting a material regulatory event: Nasdaq has issued a Staff Determination Letter threatening delisting after the bid price stayed under $1 for 30 consecutive days. Technicals reinforce weakness – the 20‑day SMA (0.27) sits well under the 50‑day SMA (0.34) and 200‑day SMA (0.66), the 14‑day RSI is at 36.9 (oversold territory), and the MACD histogram is negative, all pointing to a bearish momentum. Financially, the firm posts negative gross (‑24%) and operating margins, a high debt‑to‑equity ratio exceeding 100%, and a ROE of ‑86%, while cash on hand barely covers its debt. Volatility is extreme at over 260% 30‑day, and beta of 0.87 suggests market‑linked swings. Given the confluence of regulatory pressure, deteriorating fundamentals, and bearish technical signals, short‑term exposure is highly risky.
Long‑term investors may view the massive valuation gap as a speculative upside opportunity if the company can resolve its listing issues, restructure debt, and return to profitability, but such a turnaround remains uncertain.
Long‑term investors may view the massive valuation gap as a speculative upside opportunity if the company can resolve its listing issues, restructure debt, and return to profitability, but such a turnaround remains uncertain.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Nasdaq delisting notice
- Bearish MACD and RSI below 40
- Price below identified support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential resolution of listing issue
- Extreme price volatility
- Continued negative earnings and high leverage
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- DCF fair value suggests large upside
- Possible strategic turnaround or restructuring
- Industry exposure to high‑growth optical and AI applications
Key Metrics & Analysis
Financial Health
Revenue Growth-24.60%
Profit Margin-119.72%
ROE-86.63%
ROA-27.11%
Debt/Equity109.06
P/B Ratio2.1
Op. Cash Flow$4.0M
Free Cash Flow$23.4M
Industry P/E35.3
Technical Analysis
TrendBearish
RSI36.9
Support$0.15
Resistance$0.60
MA 20$0.27
MA 50$0.34
MA 200$0.66
MACDBearish
VolumeIncreasing
Fear & Greed Index83.38
Valuation
Fair Value$6.63
GradeUndervalued
TypeValue
Risk Assessment
Beta0.87
Volatility266.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.